TherapeuticsMD (TXMD) Dividends payables (2010 - 2013)
TherapeuticsMD (TXMD) reported Dividends payables of $41359.0 for Q3 2013, little changed quarter-over-quarter from $41359.0 in Q2 2013.
TherapeuticsMD (TXMD) Dividends payables (2010 - 2013) Analysis & Trends
TherapeuticsMD has reported Dividends payables for 4 years, with the latest figure at $41359.0 in Q3 2013.
- For the quarter ending Q3 2013, Dividends payables changed N/A year-over-year to $41359.0; the trailing twelve-month figure through Sep 2013 stood at $41359.0 (changed N/A YoY), and the FY2012 full-year result was $41359.0, changed N/A from the prior year.
- Dividends payables for Q3 2013 stood at $41359.0, roughly flat from $41359.0 in the prior quarter.
- The five-year high for Dividends payables was $41359.0 in Q4 2010, with the low at $41359.0 in Q4 2010.
- Historically, Dividends payables has averaged $41359.0 across 4 years, with a median of $41359.0 in 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 224.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 41,359.00 |
| Jun 30, 2013 | 41,359.00 |
| Dec 31, 2012 | 41,359.00 |
| Sep 30, 2011 | 41,359.00 |
| Jun 30, 2011 | 41,359.00 |
| Dec 31, 2010 | 41,359.00 |